🇺🇸 FDA
Patent

US 11951121

Compositions and methods for treating Huntington's disease

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11951121 (Compositions and methods for treating Huntington's disease) held by VOYAGER THERAPEUTICS, INC. expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/7105, A61K31/713, A61K48/0025, A61K48/005